Jiangsu Lanfeng Bio-chemical Co Ltd (002513) Fair Value & Analysis
Basic Materials · CN · Market cap 2.0B CNY (≈ $306M) · ISIN CNE100000XP5
What is Jiangsu Lanfeng Bio-chemical Co Ltd really worth?
Below-average quality, and trading another 315% above our fair value of ¥1.30.
Risks
Fair value as of: Aug 13, 2026
From 4 valuation models · updated 22 days ago
Fair value updated Aug 13, 2026, revised from ¥1.49 to ¥1.30 (−12.8%) since Jul 22, 2026. Share price +8.4% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (¥1.83). The favourable scenario is already priced in.
- Weak quality (39/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The model range is unusually wide (¥0.7000 to ¥1.83). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ¥3.11 – ¥10.40 · fair‑value band ¥0.7000 – ¥1.83 · the ¥5.40 price screens above the ¥1.30 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Jiangsu Lanfeng Bio-chemical Co Ltd (002513) currently trades at ¥5.40, while our model-based Fair Value estimate is ¥1.30, implying the stock looks roughly 315.5% overvalued today. The Quality Score stands at 39/100 (below-average quality), in the Basic Materials sector. Bull case: the Multiples group reads highest at a median of ¥1.60 per share, and 0 of the 4 models we run sit above the ¥5.40 price. Bear case: the Dividend Discount group reads lowest at ¥1.30, and 4 of the 4 models stay below the price. Evidence for this calculation is low.
Over the trailing twelve months, Jiangsu Lanfeng Bio-chemical Co Ltd generated revenue of 2.5B CNY at a net margin of −7.5%. Revenue grew 19.9% year over year. It earns a return on equity of −83.9%. Net debt stands at 194M CNY. Fundamentals as of Aug 13, 2026
Our scenario range runs from ¥0.7000 (bear case) to ¥1.83 (bull case); at ¥5.40, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 53% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at 9% fair-value upside, at −76%, 002513 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 4 models by family
Widest divergence: Multiples (¥1.60) versus Asset-Based (¥0.0800). Highest evidence: Gordon GGM (67).
Notify me when 002513 reaches fair value
Put 002513 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 39 · Market factors (momentum, volatility) 23
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers carbendazim, thiophanate-methyl, cycloazinone, carbosulfan butyl, sulfuric acid, and surfactant.
Full company description
Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers carbendazim, thiophanate-methyl, cycloazinone, carbosulfan butyl, sulfuric acid, and surfactant. Jiangsu Lanfeng Bio-chemical Co.,Ltd was founded in 1976 and is based in Xinyi, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Jiangsu Lanfeng Bio-chemical Co Ltd reported revenue of 2.3B CNY in FY2025 versus 1.4B CNY in FY2021, a compound +12.9%/yr. Reported net income was −191M CNY in FY2025.
002513 screens 315% overvalued. Compare with Corteva, Inc →
Peer Group
Agricultural Inputs · 175 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Agricultural Inputs median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $78.57 | $27.81 | −65% |
| Nutrien Ltd NTR | C$103.71 | C$113.16 | +9% |
| Qinghai Salt Lake Industry Co 000792 | ¥27.65 | ¥21.26 | −23% |
| CF Industries Holdings CF | $125.79 | $161.00 | +28% |
| SABIC Agri-Nutrients Company 2020 | 122.90 SAR | 127.31 SAR | +4% |
| Yara International ASA YAR | kr 437.20 | kr 630.39 | +44% |
| Yunnan Yuntianhua Co 600096 | ¥31.58 | ¥42.12 | +33% |
| The Mosaic Company MOS | $23.60 | $28.68 | +22% |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥45.86 | ¥38.01 | −17% |
| ICL Group ICL | $5.47 | $2.98 | −46% |
Compare Jiangsu Lanfeng Bio-chemical Co Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Jiangsu Lanfeng Bio-chemical Co Ltd (002513) overvalued or undervalued?
What is the fair value of 002513?
What is the quality score of 002513?
What is the revenue of Jiangsu Lanfeng Bio-chemical Co Ltd (002513)?
What is the net profit margin of 002513?
Does Jiangsu Lanfeng Bio-chemical Co Ltd pay a dividend?
Watch Jiangsu Lanfeng Bio-chemical Co Ltd in the live analysis
One click puts Jiangsu Lanfeng Bio-chemical Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.